# Amgen Inc. (AMGN) — Q2-2024 Earnings Results

**Report date:** 2024-08-06 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2024

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Up 1.15%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $4.97 | N/A | +0.81% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting their commitment to shareholder value. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value to our shareholders.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's strong EPS performance indicates effective cost management and operational efficiency. The stock's 1.15% increase suggests that investors reacted positively to the earnings beat, despite the lack of revenue data and future guidance. This could reflect confidence in the company's ongoing strategies.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q2-2024_